BeStock  
Stocks › Biotechnology › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2344Biotechnology
$29.96 −$1.48 (-4.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $29.96 0.00%
Open$31.12
Prev close$31.44
Day range$29.87 – $31.75
Volume1.75M
Market cap$3.40B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$40.43+34.9% vs. price
  • Buy 100%
Low $33.00Now $29.96Avg $40.43High $53.00

Recent rating changes

The last 20 actions on file set price targets from $26.00 to $53.00, averaging $37.79.

DateFirmRatingTarget
9 Nov 2026 Wells Fargo BUY $39.00
9 Nov 2026 H.C. Wainwright BUY $40.00
5 Nov 2026 Wells Fargo BUY $34.00
5 Nov 2026 Wedbush BUY $42.00
5 Nov 2026 Evercore BUY $33.00
5 Nov 2026 H.C. Wainwright BUY $40.00
5 Nov 2026 RBC Capital BUY $41.00
4 Nov 2026 Wedbush BUY $42.00
4 Nov 2026 Goldman Sachs BUY $53.00
3 Nov 2026 Wedbush BUY $41.00
30 Oct 2026 Evercore BUY $26.00
14 Oct 2026 Wells Fargo BUY $31.00
8 Oct 2026 RBC Capital BUY $38.00
2 Oct 2026 LifeSci Capital BUY $35.00
22 Sep 2026 RBC Capital BUY $38.00
1 Sep 2026 Truist Financial BUY –
19 Aug 2026 Goldman Sachs BUY $40.00
13 Aug 2026 Stifel BUY $40.00
11 Aug 2026 Truist Financial BUY $39.00
10 Aug 2026 Evercore BUY $26.00

Discussion

No comments yet — be the first to weigh in on VRDN.

Sign in to join the discussion.

Scroll to Top